Clinical Trial Update: Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating PF-03049423 for ischemic stroke was terminated, and the results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• PF-03049423

Snippet

Sponsor: Pfizer | Conditions: Ischemic Stroke | Phase 2 | Status: TERMINATED | Results posted: 2016-02-19